Skip to main content
British Journal of Cancer logoLink to British Journal of Cancer
. 1999 Jan;79(2):211–213. doi: 10.1038/sj.bjc.6690035

Lack of DMBT1 expression in oesophageal, gastric and colon cancers

M Mori 1, T Shiraishi 1, S Tanaka 1, M Yamagata 1, K Mafune 2, Y Tanaka 3, H Ueo 4, G F Barnard 5, K Sugimachi 6
PMCID: PMC2362205  PMID: 9888459

Abstract

Loss of sequences from human chromosome 10q has been reported in several different cancers. Recently, a second candidate tumour-suppressor gene, DMBT1, was identified in this chromosomal region. We studied the mRNA expression and homozygous deletion of this gene in human oesophageal, gastric and colon cancers. Reverse transcriptase polymerase chain reaction (RT-PCR) amplification demonstrated that 23 (53.5%) of 43 oesophageal, 5 (12.5%) of 40 gastric, and 4 (16.7%) of 24 colorectal cancer cases showed an apparent reduction in DMBT1 mRNA in tumour tissues compared with paired normal tissues. Twelve out of 15 oesophageal cancer cell lines also showed no expression. We next studied homozygous deletions within the DMBT1 gene in oesophageal cancers by using duplex PCR. Consequently, it was recognized in five (11.6%) of the primary tumours and two (13.3%) of the cell lines. These findings suggest that DMBT1 may act as a tumour-suppressor gene not only in brain tumours but also in gastrointestinal cancers, especially in oesophageal cancers. © 1999 Cancer Research Campaign

Keywords: DMBT1 gene, tumour-suppressor gene, oesophageal cancer, gastrointestinal cancer, homozygous deletion

Full Text

The Full Text of this article is available as a PDF (72.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Albarosa R., Colombo B. M., Roz L., Magnani I., Pollo B., Cirenei N., Giani C., Conti A. M., DiDonato S., Finocchiaro G. Deletion mapping of gliomas suggest the presence of two small regions for candidate tumor-suppressor genes in a 17-cM interval on chromosome 10q. Am J Hum Genet. 1996 Jun;58(6):1260–1267. [PMC free article] [PubMed] [Google Scholar]
  2. Aoki T., Mori T., Du X., Nisihira T., Matsubara T., Nakamura Y. Allelotype study of esophageal carcinoma. Genes Chromosomes Cancer. 1994 Jul;10(3):177–182. doi: 10.1002/gcc.2870100305. [DOI] [PubMed] [Google Scholar]
  3. Gray I. C., Phillips S. M., Lee S. J., Neoptolemos J. P., Weissenbach J., Spurr N. K. Loss of the chromosomal region 10q23-25 in prostate cancer. Cancer Res. 1995 Nov 1;55(21):4800–4803. [PubMed] [Google Scholar]
  4. Hahn S. A., Seymour A. B., Hoque A. T., Schutte M., da Costa L. T., Redston M. S., Caldas C., Weinstein C. L., Fischer A., Yeo C. J. Allelotype of pancreatic adenocarcinoma using xenograft enrichment. Cancer Res. 1995 Oct 15;55(20):4670–4675. [PubMed] [Google Scholar]
  5. Herbst R. A., Weiss J., Ehnis A., Cavenee W. K., Arden K. C. Loss of heterozygosity for 10q22-10qter in malignant melanoma progression. Cancer Res. 1994 Jun 15;54(12):3111–3114. [PubMed] [Google Scholar]
  6. Kong D., Suzuki A., Zou T. T., Sakurada A., Kemp L. W., Wakatsuki S., Yokoyama T., Yamakawa H., Furukawa T., Sato M. PTEN1 is frequently mutated in primary endometrial carcinomas. Nat Genet. 1997 Oct;17(2):143–144. doi: 10.1038/ng1097-143. [DOI] [PubMed] [Google Scholar]
  7. Li J., Yen C., Liaw D., Podsypanina K., Bose S., Wang S. I., Puc J., Miliaresis C., Rodgers L., McCombie R. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science. 1997 Mar 28;275(5308):1943–1947. doi: 10.1126/science.275.5308.1943. [DOI] [PubMed] [Google Scholar]
  8. Mollenhauer J., Wiemann S., Scheurlen W., Korn B., Hayashi Y., Wilgenbus K. K., von Deimling A., Poustka A. DMBT1, a new member of the SRCR superfamily, on chromosome 10q25.3-26.1 is deleted in malignant brain tumours. Nat Genet. 1997 Sep;17(1):32–39. doi: 10.1038/ng0997-32. [DOI] [PubMed] [Google Scholar]
  9. Mori M., Mimori K., Inoue H., Barnard G. F., Tsuji K., Nanbara S., Ueo H., Akiyoshi T. Detection of cancer micrometastases in lymph nodes by reverse transcriptase-polymerase chain reaction. Cancer Res. 1995 Aug 1;55(15):3417–3420. [PubMed] [Google Scholar]
  10. Mori M., Mimori K., Ueo H., Tsuji K., Shiraishi T., Barnard G. F., Sugimachi K., Akiyoshi T. Clinical significance of molecular detection of carcinoma cells in lymph nodes and peripheral blood by reverse transcription-polymerase chain reaction in patients with gastrointestinal or breast carcinomas. J Clin Oncol. 1998 Jan;16(1):128–132. doi: 10.1200/JCO.1998.16.1.128. [DOI] [PubMed] [Google Scholar]
  11. Peiffer S. L., Herzog T. J., Tribune D. J., Mutch D. G., Gersell D. J., Goodfellow P. J. Allelic loss of sequences from the long arm of chromosome 10 and replication errors in endometrial cancers. Cancer Res. 1995 May 1;55(9):1922–1926. [PubMed] [Google Scholar]
  12. Petersen I., Langreck H., Wolf G., Schwendel A., Psille R., Vogt P., Reichel M. B., Ried T., Dietel M. Small-cell lung cancer is characterized by a high incidence of deletions on chromosomes 3p, 4q, 5q, 10q, 13q and 17p. Br J Cancer. 1997;75(1):79–86. doi: 10.1038/bjc.1997.13. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES